id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2011-N-0902-0005,FDA,FDA-2011-N-0902,Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Prescription Drug Product Labeling; Medication Guide Requirements,Notice,Notice of Approval,2013-05-14T04:00:00Z,2013,5,2013-05-14T04:00:00Z,,2013-05-14T14:50:56Z,2013-11364,0,0,09000064812e2fce